volume 39 issue 1 pages 302-327

Gold nanoparticles in ophthalmology

Publication typeJournal Article
Publication date2018-05-16
scimago Q1
wos Q1
SJR3.169
CiteScore29.5
Impact factor11.6
ISSN01986325, 10981128
PubMed ID:  29766541
Drug Discovery
Pharmacology
Molecular Medicine
Abstract
Many research projects are underway to improve the diagnosis and therapy in ophthalmology. Indeed, visual acuity deficits affect 285 million people worldwide and different strategies are being developed to strengthen patient care. One of these strategies is the use of gold nanoparticles (GNP) for their multiple properties and their ability to be used as both diagnosis and therapy tools. This review exhaustively details research developing GNPs for use in ophthalmology. The toxicity of GNPs and their distribution in the eye are described through in vitro and in vivo studies. All publications addressing the pharmacokinetics of GNPs administered in the eye are extensively reviewed. In addition, their use as biosensors or for imaging with optical coherence tomography is illustrated. The future of GNPs for ophthalmic therapy is also discussed. GNPs can be used to deliver genes or drugs through different administration routes. Their antiangiogenic and anti‐inflammatory properties are of great interest for different ocular pathologies. Finally, GNPs can be used to improve stereotactic radiosurgery, brachytherapy, and photothermal therapy because of their many properties.
Found 
Found 

Top-30

Journals

1
2
3
4
5
International Journal of Molecular Sciences
5 publications, 4.85%
Pharmaceutics
5 publications, 4.85%
Nanomaterials
4 publications, 3.88%
Journal of Nanobiotechnology
4 publications, 3.88%
Therapeutic Advances in Ophthalmology
2 publications, 1.94%
Molecules
2 publications, 1.94%
Frontiers in Medicine
2 publications, 1.94%
Drug Delivery and Translational Research
2 publications, 1.94%
Scientific Reports
2 publications, 1.94%
International Journal of Pharmaceutics
2 publications, 1.94%
Biomaterials Science
2 publications, 1.94%
Nanoscale
2 publications, 1.94%
Biomedicine and Pharmacotherapy
2 publications, 1.94%
Journal of Drug Delivery Science and Technology
2 publications, 1.94%
Recent Patents on Drug Delivery and Formulation
1 publication, 0.97%
Translational Vision Science and Technology
1 publication, 0.97%
Genes
1 publication, 0.97%
Coatings
1 publication, 0.97%
Gels
1 publication, 0.97%
Materials
1 publication, 0.97%
Frontiers in Molecular Biosciences
1 publication, 0.97%
Optics
1 publication, 0.97%
Topics in Catalysis
1 publication, 0.97%
Current Ophthalmology Reports
1 publication, 0.97%
Nature Nanotechnology
1 publication, 0.97%
Colloids and Surfaces B: Biointerfaces
1 publication, 0.97%
Advances in Natural Sciences: Nanoscience and Nanotechnology
1 publication, 0.97%
Drug Discovery Today
1 publication, 0.97%
Polymers
1 publication, 0.97%
1
2
3
4
5

Publishers

5
10
15
20
25
Elsevier
25 publications, 24.27%
MDPI
23 publications, 22.33%
Springer Nature
17 publications, 16.5%
Wiley
7 publications, 6.8%
Royal Society of Chemistry (RSC)
5 publications, 4.85%
American Chemical Society (ACS)
4 publications, 3.88%
Frontiers Media S.A.
3 publications, 2.91%
Bentham Science Publishers Ltd.
2 publications, 1.94%
SAGE
2 publications, 1.94%
Cold Spring Harbor Laboratory
2 publications, 1.94%
Association for Research in Vision and Ophthalmology (ARVO)
1 publication, 0.97%
IOP Publishing
1 publication, 0.97%
Shenyang Pharmaceutical University
1 publication, 0.97%
Taylor & Francis
1 publication, 0.97%
Walter de Gruyter
1 publication, 0.97%
American Association for the Advancement of Science (AAAS)
1 publication, 0.97%
Hindawi Limited
1 publication, 0.97%
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.97%
Pleiades Publishing
1 publication, 0.97%
The Russian Academy of Sciences
1 publication, 0.97%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.97%
5
10
15
20
25
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
104
Share
Cite this
GOST |
Cite this
GOST Copy
Masse F. et al. Gold nanoparticles in ophthalmology // Medicinal Research Reviews. 2018. Vol. 39. No. 1. pp. 302-327.
GOST all authors (up to 50) Copy
Masse F., Ouellette M., Lamoureux G., Boisselier E. Gold nanoparticles in ophthalmology // Medicinal Research Reviews. 2018. Vol. 39. No. 1. pp. 302-327.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/med.21509
UR - https://doi.org/10.1002/med.21509
TI - Gold nanoparticles in ophthalmology
T2 - Medicinal Research Reviews
AU - Masse, Florence
AU - Ouellette, Mathieu
AU - Lamoureux, Guillaume
AU - Boisselier, Elodie
PY - 2018
DA - 2018/05/16
PB - Wiley
SP - 302-327
IS - 1
VL - 39
PMID - 29766541
SN - 0198-6325
SN - 1098-1128
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2018_Masse,
author = {Florence Masse and Mathieu Ouellette and Guillaume Lamoureux and Elodie Boisselier},
title = {Gold nanoparticles in ophthalmology},
journal = {Medicinal Research Reviews},
year = {2018},
volume = {39},
publisher = {Wiley},
month = {may},
url = {https://doi.org/10.1002/med.21509},
number = {1},
pages = {302--327},
doi = {10.1002/med.21509}
}
MLA
Cite this
MLA Copy
Masse, Florence, et al. “Gold nanoparticles in ophthalmology.” Medicinal Research Reviews, vol. 39, no. 1, May. 2018, pp. 302-327. https://doi.org/10.1002/med.21509.